Table 2.
SLD variable | Healthy volunteers and initial cohort | Initial cohort | Confirmatory cohort | ||||||
---|---|---|---|---|---|---|---|---|---|
Volunteers (n = 18) | Patients (n = 29) | P | Survivors (n = 18) | Non-survivors (n = 11) | P | Survivors (n = 17) | Non-survivors (n = 18) | P | |
Skin blood flow 37 °C (PU) | 10.3 (8.0–14.2) | 13.0 (10.1–19.5) | 0.16 | 13.4 (10.0–21.6) | 13.0 (10.1–19.5) | 0.44 | 12.4 (8.0–17.3) | 15.0 (10.2–19.3) | 0.44 |
Skin blood flow 43 °C (PU) | 112.8 (88.0–150.0) | 36.4 (25.6–76.9) | < 0.01 | 51.8 (25.6–77.2) | 33.7 (16.5–39.0) | 0.76 | 57.4 (41.5–71.5) | 33.1 (21.8–41.6) | < 0.01 |
Skin blood flow ratio | 11.2 (9.4–13.4) | 2.6 (2.0–3.6) | < 0.01 | 3.2 (2.2–6.2) | 2.3 (1.7–2.8) | < 0.01 | 3.7 (2.9–6.2) | 2.1 (1.6–2.5) | < 0.01 |
PU perfusion units